Cite
HARVARD Citation
Lumb, S. et al. (2013). THU0045 Epratuzumab, an Antibody Targeting CD22 on B Cells, Induces Phosphoprotein Changes Following B-Cell Receptor Activation in Vitro. Annals of the rheumatic diseases. p. A179. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lumb, S. et al. (2013). THU0045 Epratuzumab, an Antibody Targeting CD22 on B Cells, Induces Phosphoprotein Changes Following B-Cell Receptor Activation in Vitro. Annals of the rheumatic diseases. p. A179. [Online].